Kaleido Biosciences Inc
Last update: 4:02PM (Delayed 15-Minutes)
Get Real Time Here
Vol / Avg.0 / 4.005KMkt Cap4.262K
Day Range- - -52 Wk Range0.000 - 0.030

Kaleido Biosciences Stock (OTC:KLDO), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1


Highest Price Target1


Lowest Price Target1


Consensus Price Target1


Analyst Rating Summary1


Analyst Firms Making Recommendations1

  • Chardan Capital
  • JMP Securities
  • Morgan Stanley
  • Piper Sandler

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Kaleido Biosciences

Upgrades (0)

Downgrades (2)

Initiations (2)

Buy Now
Current price
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
04/04/2022KLDOBuy Now
Kaleido Biosciences
$0.001699900%Chardan Capital
Keay Nakae
$3 → $1.7DowngradeBuy → NeutralGet Alert
01/31/2022KLDOBuy Now
Kaleido Biosciences
$0.002999900%Chardan Capital
Keay Nakae
$11 → $3MaintainsBuyGet Alert
11/12/2021KLDOBuy Now
Kaleido Biosciences
$0.0010999900%Chardan Capital
Keay Nakae
MaintainsBuyGet Alert
11/03/2021KLDOBuy Now
Kaleido Biosciences
$0.0021999900%JMP Securities
Gobind Singh
MaintainsMarket OutperformGet Alert
10/19/2021KLDOBuy Now
Kaleido Biosciences
$0.002999900%Morgan Stanley
Matthew Harrison
DowngradeEqual-Weight → UnderweightGet Alert
03/08/2021KLDOBuy Now
Kaleido Biosciences
$0.0011999900%Morgan Stanley
Matthew Harrison
MaintainsEqual-WeightGet Alert
02/09/2021KLDOBuy Now
Kaleido Biosciences
$0.0018999900%Piper Sandler
Edward Tenthoff
Initiates → OverweightGet Alert
01/19/2021KLDOBuy Now
Kaleido Biosciences
$0.0012999900%Morgan StanleyMaintainsEqual-WeightGet Alert
12/23/2020KLDOBuy Now
Kaleido Biosciences
$0.0021999900%JMP SecuritiesInitiates → OutperformGet Alert

What is the target price for Kaleido Biosciences (KLDO)?


The latest price target for Kaleido Biosciences (OTCEM: KLDO) was reported by Chardan Capital on April 4, 2022. The analyst firm set a price target for $1.70 expecting KLDO to rise to within 12 months (a possible 1699900.00% upside). 0 analyst firms have reported ratings in the last year.


What is the most recent analyst rating for Kaleido Biosciences (KLDO)?


The latest analyst rating for Kaleido Biosciences (OTCEM: KLDO) was provided by Chardan Capital, and Kaleido Biosciences downgraded their neutral rating.


When is the next analyst rating going to be posted or updated for Kaleido Biosciences (KLDO)?


Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kaleido Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kaleido Biosciences was filed on April 4, 2022 so you should expect the next rating to be made available sometime around April 4, 2023.


Is the Analyst Rating Kaleido Biosciences (KLDO) correct?


While ratings are subjective and will change, the latest Kaleido Biosciences (KLDO) rating was a downgraded with a price target of $3.00 to $1.70. The current price Kaleido Biosciences (KLDO) is trading at is $0.00, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.